• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human Peripheral Blood CD8+ Naive T Killer Cells

  • For research use only

Cat No.

ABC-TC3989

Product Type

Immune Cells

Cell Type

T Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Storage

Liquid Nitrogen

Human Peripheral Blood CD8+ Naive T Killer Cells support T-cell activation and cytotoxicity studies in infectious diseases and cancer models.

Product Image

Description

Human Peripheral Blood CD8+ Naive T Killer Cells are collected from the peripheral blood of healthy donors and cryopreserved after primary culture. These cells are a subset of cytotoxic T cells that have not encountered their cognate antigen and are characterized by the expression of CD8. They play a central role in initiating cellular immune responses and are critical for defending against intracellular pathogens and cancerous cells. CD8+ naive T cells are important in studies of immune memory formation, T cell differentiation, and immunotherapy development. In vitro, these cells exhibit limited proliferative capacity. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Peripheral Blood CD8+ Naive T Killer Cells, PB CD8+ Naïve CTLs, Naïve Cytotoxic T Cells, CD8+ Naïve Lymphocytes

Species

Human

Cat.No

ABC-TC3989

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

T Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Peripheral Blood CD8+ Naive T Killer Cells offer a valuable model for exploring antigen-specific cytotoxic responses and CD8+ T cell activation. These cells enable studies on clonal expansion, memory differentiation, and effector function development following antigen stimulation. They are especially relevant for research on cancer vaccines, viral infections, and personalized T cell-based immunotherapy.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Peripheral Blood CD8+ Naive T Killer Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button